© Springer Nature Switzerland AG 2021
C. S. Foster et al. (eds.)Uveitishttps://doi.org/10.1007/978-3-030-52974-1_34

34. Leprosy

Andrew Phillips Stephenson1  
(1)
University of Cincinnati College of Medicine, Cincinnati, OH, USA
 
 
Andrew Phillips Stephenson
Keywords
LeprosyUveitis

Overview

  • Definition
    • A chronic granulomatous bacterial infection caused by Mycobacterium leprae, mainly affecting the skin, peripheral nerves, nasal mucosa, and eye

    • Also known as Hansen’s disease

    • Infection develops very slowly (can take up to 20 years), and possibly spreads through respiratory droplets, but only after prolonged exposure to untreated individuals; it does not transmit vertically from mother to fetus

    • The three major causes of visual disability are as follows
      • Exposure or neurotrophic keratopathy

      • Chronic iridocyclitis with hypotony

      • Cataract formation

  • Symptoms
    • Pain

    • Redness

    • Photophobia

  • Laterality
    • Bilateral

  • Course
    • Leprosy is highly curable once diagnosis is made and proper therapy is commenced

    • Lepromatous uveitis is typically chronic, with little symptomatology

    • Profound hypotony and phthisis bulbi may ensure if systemic disease and ocular inflammation are not addressed

  • Age of onset
    • Two peaks: 10–14 years and 35–44 years

  • Gender/race
    • Slight male predominance

    • Very rare in the United States; armadillos are naturally infected in Southern United States

    • Between 200,000 and 250,000 new cases per year worldwide

  • Systemic association
    • Skin
      • Hypopigmented or reddish skin lesions that are numb to heat and touch, thus at risk of cuts and ulcers

      • Painless swelling or nodules on the face or earlobes

    • Peripheral nerves
      • Enlarged peripheral nerves that are hard and tender to touch
        • Predilection for ulnar, posterior tibial, and external popliteal nerves

      • Untreated, advanced leprosy results in paralysis of hand and feet

    • Nasal mucosa
      • Epistaxis

      • Saddle-nose deformity

Exam: Ocular

External

  • Loss of brow hair or lashes

  • Lagophthalmos (facial nerve paralysis)

Anterior Segment

  • Exposure or neurotrophic keratopathy
    • Focal enlarged corneal nerves, resembling beads on a string (pathognomonic)

  • Iridocyclitis is more often chronic than acute
    • IOP is often low

  • “Iris pearls.”
    • Pathognomonic

    • Arise deep in the stroma of the iris and are opaque, dense, creamy yellow, and firm (in contrast to Koeppe nodules, which are grayish, semi-translucent, and soft in appearance)

  • Diffuse episcleritis/scleritis

Posterior Segment

  • “Pearls” in anterior choroid

  • Nonspecific hyperpigmentation or hypopigmentation of the RPE

  • Focal or disseminated choroiditis (rare)

Exam: Systemic

  • Hypopigmented or reddish skin lesions with thickening and numbness to heat and touch

  • Hand and feet numbness and paralysis; painless ulcers on soles of feet

  • Enlarged nerves that are hard and tender to touch (ulnar, posterior tibial, external popliteal)

  • Saddle-nose deformity, epistaxis

Imaging

  • N/A

Laboratory and Radiographic Testing

  • Diagnosis made primarily on clinical findings

  • Skin, earlobe, nerve, or nasal mucosa smear/biopsy for M. leprae (acid-fast staining)

  • Isolation of M. leprae from conjunctival tissue, scleral nodules, aqueous, or iris tissue

Differential Diagnosis

  • Chronic granulomatous iridocyclitis
    • Sarcoidosis

    • Lyme disease

    • Syphilis

    • Tuberculosis (TB)

    • Herpesviruses

  • Skin lesions can vary widely; some top differentials include:
    • Allergic contact dermatitis

    • Neurofibromatosis

    • Lupus vulgaris (cutaneous TB)

    • Systemic lupus erythematosus

    • Cutaneous sarcoidosis

    • Lichen planus

    • Psoriasis

    • Granuloma annulare

    • Onchocerciasis

    • Leishmaniasis

    • Tinea versicolor

    • Tinea corporis

    • Syphilis

Treatment

  • Early treatment of leprosy reduces ocular involvement

  • Multi-drug therapy (MDT) is curative after 1–2 years, involving 2 or 3 of the following depending on the form and severity of leprosy
    • Rifampicin

    • Dapsone

    • Clofazimine

Referral/Comanagement

  • Infectious disease

  • Dermatology